☰
Skip to content
Home
Studies
BioFINDER One
BioFINDER Two
BioFINDER Sleep
BioFINDER Preclinical AD
BioFINDER Primary Care
BioFINDER Memory Clinic
Study Group
Publications
News
Deltagare / Participants
APOE4 impact on soluble and insoluble tau pathology is mostly influenced by amyloid-beta.
2025
Brain. 2025 Jan 16:awaf016. doi: 10.1093/brain/awaf016. Online ahead of print. PMID: 39817469
Cicognola C, Salvadó G, Smith R, Palmqvist S, Stomrud E, Betthauser T, Johnson S, Janelidze S, Mattsson-Carlgren N, Hansson O, Pichet Binette A.
Brain. 2025 Jan 16:awaf016. doi: 10.1093/brain/awaf016. Online ahead of print. PMID: 39817469
2026
Biological classification of memory clinic patients
2026
Reference proteins to improve Core 1 and Core 2 Alzheimer’s disease CSF and plasma biomarkers
2026
A deep joint-learning proteomics model for diagnosis of six conditions associated with dementia
2026
Eligibility for amyloid targeting therapies among primary care patients with cognitive symptoms
2026
Integration of plasma eMTBR-tau243 and p-tau217 in the diagnosis and stratification of Alzheimer’s disease: a prospective cohort study
2026
Identification of distinct and shared biomarker panels in different manifestations of cerebral small-vessel disease through proteomic profiling
2026
High- and Low-Fat Dairy Consumption and Long-Term Risk of Dementia: Evidence From a 25-Year Prospective Cohort Study
2026
A minimally invasive dried blood spot biomarker test for the detection of Alzheimer’s disease pathology
2026
Associations of modifiable and non-modifiable risk factors with longitudinal white matter hyperintensities, amyloid-β and tau – a prospective cohort study
2026
A review of evidence supporting amyloid beta reduction as a surrogate endpoint in Alzheimer’s disease
2025
STEM-PD trial protocol: a multi-centre, single-arm, first-in-human, dose-escalation trial, investigating the safety and tolerability of intraputamenal transplantation of human embryonic stem cell-derived dopaminergic cells for Parkinson’s disease
2025
Clinical recognition of frontotemporal dementia with right temporal predominance: a consensus statement from the International Working Group
2025
Treatment-related amyloid clearance (TRAC): a framework to characterize patients in the era of anti-amyloid therapies
2025
Prediction of continuous amyloid positron emission tomography with fluid measures of phosphorylated tau and β-amyloid
2025
Locus coeruleus-entorhinal cortex tract integrity is linked to plasma tau and glial fibrillary acidic protein